Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.6800
-1.1400 (-11.61%)
NASDAQ· Last Trade: Jun 2nd, 3:07 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026